Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma. (Q33961207)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

title

Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

author name string

Sebastien J Hotte

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

Eric W Winquist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

Larry Stitt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

Sylvia M Wilson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 August 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

volume

95

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

506-512

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12209742 AND SRC:MED&resulttype=core&format=json

12 November 2019

cites work

Cancer statistics, 2000.

1 reference

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group

21 January 2018

1 reference

Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.

21 January 2018

1 reference

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

21 January 2018

1 reference

The nature and significance of osteopontin

21 January 2018

1 reference

Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily

21 January 2018

1 reference

Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women

21 January 2018

1 reference

21 January 2018

2 references

21 January 2018

7 January 2021

Osteopontin: a versatile regulator of inflammation and biomineralization

1 reference

Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells

21 January 2018

1 reference

Receptor-ligand interaction between CD44 and osteopontin (Eta-1)

21 January 2018

1 reference

NF-kappaB mediates alphavbeta3 integrin-induced endothelial cell survival

21 January 2018

1 reference

Osteopontin stimulates a subpopulation of quiescent human prostate epithelial cells with high proliferative potential to divide in vitro

21 January 2018

1 reference

Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues

21 January 2018

1 reference

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

21 January 2018

1 reference

MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS

21 January 2018

1 reference

7 January 2021

Change in serum prostate-specific antigen as a marker of response to cytotoxic therapy for hormone-refractory prostate cancer

1 reference

7 January 2021

Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: a phase II trial

1 reference

7 January 2021

Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancer

1 reference

7 January 2021

Osteopontin expression detected in adult cochleae and inner ear fluids

1 reference

7 January 2021

Evidence that a non-RGD domain in rat osteopontin is involved in cell attachment

1 reference

7 January 2021

Rat osteoclasts adhere to a wide range of RGD (Arg-Gly-Asp) peptide-containing proteins, including the bone sialoproteins and fibronectin, via a beta 3 integrin

1 reference

7 January 2021

Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met)

1 reference

7 January 2021

Ca2 and protein kinase C activation of mucin granule exocytosis in permeabilized SPOC1 cells.

1 reference

7 January 2021

Osteopontin expression in a group of lymph node negative breast cancer patients

1 reference

7 January 2021